BD and ten23 health Partner to Create RFID-Enabled Prefillable Syringes

BD (Becton, Dickinson and Company), a leading global medical technology company, and ten23 health, the human-centric and sustainable strategic CDMO partner of choice for the pharmaceutical industry and biotech start-ups, announce a collaboration to develop a new way to track prefillable syringes (PFS) using

The collaboration aims to pilot an RFID-based solution created by BD to improve manufacturing process efficiency and provide traceability of individual units. This solution will benefit ten23 health and its customers by ensuring a higher traceability throughout both the manufacturing process and the supply chain.

The new traceability solution, branded BD iDFill Individual Prefillable Syringe Identification, involves equipping each PFS with an RFID tag encoded with a unique serial number called the Container Unique Identifier (CUID). This CUID can be scanned at various stages of the manufacturing process, from filling to secondary packaging or any further assembly.

By linking the drug code, filling batch, timestamps, and other relevant data with the CUID, the solution provides full container traceability and enables multiple applications, including automated reconciliation, mix-up prevention, and investigation management. This system also helps to quickly identify and trace individual units during production and beyond.